Literature DB >> 16612628

Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis.

Tineke Hooper-van Veen1, Johannes Berkhof, Chris H Polman, Bernard M J Uitdehaag.   

Abstract

The conventional approach of candidate gene studies in complex diseases is to look at the effect of one gene at a time. However, as the outcome of chronic diseases is influenced by a large number of alleles, simultaneous analysis is needed. We demonstrate the application of multivariate regression and cluster analysis to a multiple sclerosis (MS) dataset with genotypes for 489 patients at 11 candidate genes selected on their involvement in the immune response. Using multivariate regression, we observed that different sets of genes were associated with different disease characteristics that reflect different aspects of disease. Out of 15 polymorphisms, we identified one that contributed to the severity of disease. In addition, the set of 15 polymorphisms was predictive for yearly increase in lesion volume as seen on T1-weighted MRI (p=0.044). From this set, no individual polymorphisms could be identified after adjustment for multiple hypotheses testing. By means of a cluster analysis, we aimed to identify subgroups of patients with different pathogenic subtypes of MS on the basis of their genetic profile. We constructed genetic profiles from the genotypes at the 11 candidate genes. The approach proved to be feasible. We observed three clusters in the sample of patients. In this study, we observed no significant differences in the usual clinical and MRI outcome measures between the different clusters. However, a number of consistent trends indicated that this clustering might be related to the course of disease. With a larger number of genes regulating the course of disease, we may be able to identify clinically relevant clusters. The analyses are easily implemented and will be applicable to candidate gene studies of complex traits in general.

Entities:  

Mesh:

Year:  2006        PMID: 16612628     DOI: 10.1007/s00251-006-0116-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

Review 1.  Methods in health service research. An introduction to bayesian methods in health technology assessment.

Authors:  D J Spiegelhalter; J P Myles; D R Jones; K R Abrams
Journal:  BMJ       Date:  1999-08-21

2.  Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis.

Authors:  Iraide Alloza; Shirley Heggarty; An Goris; Colin A Graham; Bénédicte Dubois; Gavin McDonnell; Stanley A Hawkins; Herwig Carton; Koen Vandenbroeck
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

3.  [Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotype.

Authors:  T van Veen; L van Winsen; J B A Crusius; N F Kalkers; F Barkhof; A S Peña; C H Polman; B M J Uitdehaag
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

Review 5.  Linkage disequilibrium in humans: models and data.

Authors:  J K Pritchard; M Przeworski
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

6.  Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.

Authors:  D Brassat; C Azais-Vuillemin; J Yaouanq; G Semana; J Reboul; I Cournu; C Mertens; G Edan; O Lyon-Caen; M Clanet; B Fontaine
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

7.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.

Authors:  C J De Groot; E Bergers; W Kamphorst; R Ravid; C H Polman; F Barkhof; P van der Valk
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

8.  Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity.

Authors:  C L A Mann; M B Davies; V L Stevenson; S M Leary; M D Boggild; C Ko Ko; P W Jones; A A Fryer; R C Strange; A J Thompson; C P Hawkins
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

9.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 10.  Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene.

Authors:  D E Comings
Journal:  Alcohol       Date:  1998-07       Impact factor: 2.405

View more
  2 in total

1.  Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study.

Authors:  M H Sombekke; M M Vellinga; B M J Uitdehaag; F Barkhof; C H Polman; D Arteta; D Tejedor; A Martinez; J B A Crusius; A S Peña; J J G Geurts; H Vrenken
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-24       Impact factor: 3.825

2.  Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis.

Authors:  Mojdeh Ghabaee; Asghar Bayati; Shahla Amri Saroukolaei; Mohamad Ali Sahraian; Mohammad Hosein Sanaati; Parisa Karimi; Massoud Houshmand; Homa Sadeghian; Leila Hashemi Chelavi
Journal:  Cell Mol Neurobiol       Date:  2008-08-26       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.